Psoriasis and atherothrombotic disease
Ahlehoff, O.; Gislason, G.H.; Skov, L.; Hansen, P.R.
Ugeskrift for Laeger 172(26): 1983-1986
2010
ISSN/ISBN: 1603-6824 PMID: 20654288 Document Number: 643971
Psoriasis and atherosclerosis share immunoinflammatory mechanisms and patients with psoriasis may carry an excess of cardiovascular risk factors (hypercholesterolemia, hypertension, obesity, metabolic syndrome, diabetes mellitus, smoking etc.) and increased risk of atherothrombotic disease. The current review summarises the available evidence in this area of research and calls for increased awareness of cardiovascular risk assessment and treatment in patients with psoriasis.
Document emailed within 1 workday
Related Documents
Howard, G.C.; Pizzo, S.V. 1993: Lipoprotein(a) and its role in atherothrombotic disease Laboratory Investigation; a Journal of Technical Methods and Pathology 69(4): 373-386Hansen, P.R. 2006: High-density lipoprotein: a new target in the battle against atherothrombotic disease Ugeskrift for Laeger 168(5): 468-470
Blann, A.D.; Lip, G.Y. 1998: The endothelium in atherothrombotic disease: assessment of function, mechanisms and clinical implications Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 9(4): 297-306
Takahashi, W. 2006: Association between intra- and extra-cranial large vessel disease in atherothrombotic infarction Nihon Rinsho. Japanese Journal of Clinical Medicine 64 Suppl. 8: 116-119
Collet, J.P.; Allali, Y.; Borentain, M.; Payot, L.; Raoux, F.; Cacoub, P.; Leys, D.; Alperovitch, A.; Montalescot, G. 2005: Prevalence of asymptomatic atherothrombotic lesions and risk of vascular events in patients with documented coronary artery disease Archives des Maladies du Coeur et des Vaisseaux 98 Spec no 4: 31-54
Bóngard, V.; Cambou, J.P.; Coppe, G.; Jullien, G.; Vahanian, A.; Mas, J.L. 2003: Prevalence and management of patients with a prior history of atherothrombotic disease in primary care in France. Results of the ECLAT1 survey Archives des Maladies du Coeur et des Vaisseaux 96(9): 833-840
Yoshida, Y. 2006: Pathophysiology of atherothrombotic infarction Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 7): 97-101
Zorzon, M.; Iona, L.G.; Masè, G.; Cazzato, G. 1986: The hematocrit and atherothrombotic cerebral infarcts Rivista di Neurologia 56(5): 300-310
Hoshino, H. 2006: Treatment and prognosis of the atherothrombotic cerebral infarction Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 8): 120-125
Solovyeva, L.N.; Shmonin, A.A.; Emanuel, Y.V.; Stolyarov, M.S.; Bondareva, E.A.; Mazing A V; Lazareva, N.M.; Kholopova, I.V.; Blinova, T.V.; Kharitonova, T.V.; Lapin, S.V.; Emanuel, V.L.; Melnikova, E.V. 2015: The Clinical Laboratory Markers of Atherosclerosis in Patients with Atherothrombotic Stroke Klinicheskaia Laboratornaia Diagnostika 60(10): 12-16
Manna, R.; Cristiano, G.; Liang, L.; Astone, A.; De Santis, A.; Sambakay, C.E.; Luchetti, R.; Romano, N.; Antico, L.; Gambassi, G. 1992: Psoriasis: an autoimmune disease Minerva Medica 83(7-8): 403-414
Kimura, K.; Yasaka, M.; Yamaguchi, T. 1994: Antihypertensive drugs in acute stage of atherothrombotic infarction deteriorate the outcome Rinsho Shinkeigaku 34(2): 114-117
David, M.; Grunwald, M.; Feuerman, E.J. 1982: Bowen's disease in a patient with psoriasis vulgaris Harefuah 102(7): 282-283
Crowley, J. 2010: Scalp psoriasis: an overview of the disease and available therapies Journal of Drugs in Dermatology: Jdd 9(8): 912-918
Kalantzi, K.I.; Ntalas, I.V.; Chantzichristos, V.G.; Tsoumani, M.E.; Adamopoulos, D.; Asimakopoulos, C.; Bourdakis, A.; Darmanis, P.; Dimitriadou, A.; Gkiokas, S.; Ipeirotis, K.; Kitikidou, K.; Klonaris, I.; Kostaki, A.; Logothetis, D.; Mainas, K.; Mais, T.; Maragiannis, A.; Martiadou, K.; Mavronasos, K.; Michelongonas, I.; Mitropoulos, D.; Papadimitriou, G.; Papadopoulos, A.; Papaioakeim, M.; Sofillas, K.; Stabola, S.; Stefanakis, E.; Stergiou, D.; Thoma, M.; Zenetos, A.; Zisekas, S.; Goudevenos, J.A.; 2019: Comparison of Triflusal with Aspirin in the Secondary Prevention of Atherothrombotic Events; Α Randomised Clinical Trial Current Vascular Pharmacology 17(6): 635-643
Bonomo, L.; Abittan, B.J..; Hashim, P.W..; Karki, C.; Mason, M.; Lebwohl, M. 2019: Combination use of Systemic Therapies in Psoriasis: Baseline Characteristics from the Corrona Psoriasis Registry Journal of Drugs in Dermatology: Jdd 18(8): 731-740
Hellgren, L. 1976: Induction of generalized pustular psoriasis by topical use of betamethasone-dipropionate ointment in psoriasis Annals of Clinical Research 8(5): 317-319
Miemiec, E. 1970: Quantitative determination of IgM in serum of patients with psoriasis vulgaris with respect to psoriasis arthropathica Dermatologische Monatschrift 156(5): 490-492
Kwan, Z.; Yeoh, C.A.; Mohd Affandi, A.; Alias, F.A.; Hamid, M.; Baharum, N.; Yong, A.S.W.; Baba, R. 2015: Causes of mortality in patients with psoriasis in Malaysia - Evidence from the Malaysian Psoriasis Registry Medical Journal of Malaysia 70(5): 273-277
Wong, J.W.; Kamangar, F.; Nguyen, T.V.; Koo, J.Y.M. 2012: Excimer laser therapy for hairline psoriasis: a useful addition to the scalp psoriasis treatment algorithm Skin Therapy Letter 17(5): 6-9